Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Gains from Sales and Divestitures (2024 - 2025)

BrightSpring Health Services (BTSG) has disclosed Gains from Sales and Divestitures for 2 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures rose 705.18% year-over-year to $1.9 million, compared with a TTM value of $1.9 million through Dec 2025, up 705.18%, and an annual FY2025 reading of $1.9 million, up 705.18% over the prior year.
  • Gains from Sales and Divestitures was $1.9 million for Q4 2025 at BrightSpring Health Services, up from $241971.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $1.9 million in Q4 2025 and bottomed at $241971.0 in Q4 2024.